Table 1.
Proposed subtypes |
|||||
---|---|---|---|---|---|
Proteins reported to be highly expressed | Philips et al.13 | Brennan et al.9 | Verhaak et al.14 | Motomura et al.16 | Le Mercier et al.15 |
Epidermal growth factor receptor (EGFR) | Proliferative and Mesenchymal GBM | EGFR core | Classical GBM | Mixed | Classical like |
CD44 | Mesenchymal GBM | Mesenchymal GBM | Astrocyticmesenchymal, Mixed | ||
Proto-oncogene tyrosine-protein kinase MER | Mesenchymal GBM | ||||
Isocitrate dehydrogenase 1 mutation | Proneural GBM | Oligodendrocyte precursor type (OPT) | |||
OLIG2 | Proneural GBM | PDGF core | Proneural GBM | Differentiated oligodendro- cyte type and OPT | |
P53 | Proneural GBM | OPT | Proneural like | ||
Platelet derived growth factor (PDGF) receptor α | PDGF core | Proneural GBM | OPT | Proneural like |